Al-Mansori Alreem, Al-Sbiei Ashraf, Bashir Ghada H, Qureshi Mohammed M, Tariq Saeed, Altahrawi Abeer, Al-Ramadi Basel K, Fernandez-Cabezudo Maria J
Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab University, Al-Ain, United Arab Emirates.
Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab University, Al-Ain, United Arab Emirates.
Heliyon. 2024 Jun 28;10(13):e33849. doi: 10.1016/j.heliyon.2024.e33849. eCollection 2024 Jul 15.
The gastrointestinal tract (GI) is the largest immune organ whose function is controlled by a complex network of neurons from the enteric nervous system (ENS) as well as the sympathetic and parasympathetic system. Evolving evidence indicates that cross-communication between gut-innervating neurons and immune cells regulates many essential physiological functions including protection against mucosal infections. We previously demonstrated that following paraoxon treatment, 70 % of the mice were able to survive an oral infection with , a virulent strain of serovar Typhimurium. The present study aims to investigate the effect that rivastigmine, a reversible AChE inhibitor used for the treatment of neurodegenerative diseases, has on the murine immune defenses of the intestinal mucosa. Our findings show that, similar to what is observed with paraoxon, administration of rivastigmine promoted the release of secretory granules from goblet and Paneth cells, resulting in increased mucin layer. Surprisingly, however, and unlike paraoxon, rivastigmine treatment did not affect overall mortality of infected mice. In order to investigate the mechanistic basis for the differential effects observed between paraoxon and rivastigmine, we used multi-color flowcytometric analysis to characterize the immune cell landscape in the intraepithelial (IE) and lamina propria (LP) compartments of intestinal mucosa. Our data indicate that treatment with paraoxon, but not rivastigmine, led to an increase of resident CD3CD8 T lymphocytes in the ileal mucosa (epithelium and lamina propria) and CD11b CD11c dendritic cells in the LP. Our findings indicate the requirement for persistent cholinergic pathway engagement to effect a change in the cellular landscape of the mucosal tissue that is necessary for protection against lethal bacterial infections. Moreover, optimal protection requires a collaboration between innate and adaptive mucosal immune responses in the intestine.
胃肠道(GI)是最大的免疫器官,其功能由来自肠神经系统(ENS)以及交感和副交感神经系统的复杂神经元网络控制。越来越多的证据表明,支配肠道的神经元与免疫细胞之间的相互交流调节着许多重要的生理功能,包括抵御黏膜感染。我们之前证明,在对氧磷处理后,70%的小鼠能够在口服感染鼠伤寒沙门氏菌毒力菌株后存活。本研究旨在调查用于治疗神经退行性疾病的可逆性乙酰胆碱酯酶抑制剂 rivastigmine 对小鼠肠道黏膜免疫防御的影响。我们的数据表明,与对氧磷处理后的情况类似,rivastigmine 的给药促进了杯状细胞和潘氏细胞分泌颗粒的释放,导致黏液层增加。然而,令人惊讶的是,与对氧磷不同,rivastigmine 处理并未影响感染小鼠的总体死亡率。为了研究对氧磷和 rivastigmine 之间观察到的差异效应的机制基础,我们使用多色流式细胞术分析来表征肠道黏膜上皮内(IE)和固有层(LP)区室中的免疫细胞格局。我们的数据表明,对氧磷处理而非 rivastigmine 处理导致回肠黏膜(上皮和固有层)中驻留的 CD3CD8 T 淋巴细胞以及 LP 中的 CD11b CD11c 树突状细胞增加。我们的研究结果表明,需要持续的胆碱能途径参与,以实现对黏膜组织细胞格局的改变,这对于抵御致命细菌感染是必要的。此外,最佳保护需要肠道中固有免疫和适应性黏膜免疫反应之间的协作。